SCHEMBL7419376

SCHEMBL7419376

CCCc1c(C(=O)CC)c2ccc(C(=O)OC)cc2n1Cc1ccccc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.43
TP53 P04637 3/20 0.43
DPP4 P27487 2/20 0.42
LMNA P02545 2/20 0.41
S1PR3 Q99500 1/20 0.41
KDM4E B2RXH2 3/20 0.40
TNF P01375 1/20 0.40
NOD2 Q9HC29 1/20 0.40
NOD1 Q9Y239 1/20 0.40
MAPK1 P28482 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
POLB P06746 1/20 0.39
PLA2G2A P14555 1/20 0.39
ALDH1A1 P00352 3/20 0.39
TDP1 Q9NUW8 1/20 0.39
HPGD P15428 1/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7415615 0.93 MAPT (0.43) MAPTTP53DPP4LMNAS1PR3
SCHEMBL7474701 0.92 MAPT (0.45) MAPTTP53DPP4LMNAS1PR3
SCHEMBL7425821 0.91 L3MBTL1 (0.45) MAPTTP53DPP4LMNAS1PR3
SCHEMBL7425356 0.91 MAPT (0.44) MAPTTP53DPP4LMNAS1PR3
SCHEMBL7416403 0.91 MAPT (0.41) MAPTTP53DPP4LMNAS1PR3
SCHEMBL7422627 0.91 S1PR3 (0.44) MAPTTP53DPP4LMNAS1PR3
SCHEMBL7418402 0.90 MAPT (0.43) MAPTTP53DPP4LMNAS1PR3
SCHEMBL7425401 0.90 MAPT (0.43) MAPTTP53DPP4LMNAS1PR3
SCHEMBL7418877 0.89 SLC22A12 (0.43) MAPTTP53DPP4KDM4ETNF
SCHEMBL7418233 0.89 MAPT (0.42) MAPTTP53DPP4LMNAS1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed